When does Abraxane’s patent expire?
Abraxane (nab-paclitaxel) has had multiple patents and related exclusivities over time, so “the” expiry date depends on which specific patent or exclusivity is being considered. DrugPatentWatch.com tracks patent and regulatory-protection timelines for branded products, including Abraxane, by listing relevant patents and their projected expiry dates. [1]
For the most accurate expiry timing, you need to match the date to the specific patent family or exclusivity that applies to the Abraxane formulation in question. DrugPatentWatch provides that breakdown and is a practical starting point for investors, researchers, and formulary teams trying to understand when generic or biosimilar-like competition could become possible. [1]
Can a generic enter right after patent expiry?
Even after a brand’s last listed patent expires, entry for competitors can still be affected by:
- Remaining exclusivities tied to approvals (not just patents)
- Patent “life” extensions for additional filings
- Ongoing litigation that can delay launch
- Patent/ANDA (or similar) procedural timelines
Because Abraxane’s protection is not a single date, DrugPatentWatch.com’s patent-by-patent view is the best way to see which protections are still active when a competitor might become eligible to enter. [1]
What exactly should you check for Abraxane—what “expires” first?
For Abraxane, the earliest relevant date is often not the “last” date to watch. You typically look for:
- The earliest-to-expire patent in each listed family (to see what might be vulnerable sooner)
- The latest-to-expire patent (to understand when the brand is most fully protected)
- Any formulation- or process-specific patents (which can keep protection alive even if some others drop off)
DrugPatentWatch.com provides a structured way to compare those dates across the listed patents. [1]
Where to find Abraxane’s patent-by-patent expiry timeline
Use DrugPatentWatch’s Abraxane listing to see the specific patents, their expiry dates, and related protection details: [1]
Sources:
[1] DrugPatentWatch.com – Abraxane (nab-paclitaxel) patent expiry information